Methyl tert-butyl ether structure
|
Common Name | Methyl tert-butyl ether | ||
|---|---|---|---|---|
| CAS Number | 1634-04-4 | Molecular Weight | 88.148 | |
| Density | 0.8±0.1 g/cm3 | Boiling Point | 55.2±0.0 °C at 760 mmHg | |
| Molecular Formula | C5H12O | Melting Point | -110 °C | |
| MSDS | Chinese USA | Flash Point | -10.0±0.0 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | methyl tert-butyl ether |
|---|---|
| Synonym | More Synonyms |
| Density | 0.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 55.2±0.0 °C at 760 mmHg |
| Melting Point | -110 °C |
| Molecular Formula | C5H12O |
| Molecular Weight | 88.148 |
| Flash Point | -10.0±0.0 °C |
| Exact Mass | 88.088814 |
| PSA | 9.23000 |
| LogP | 1.15 |
| Vapour density | 3.1 (vs air) |
| Vapour Pressure | 251.3±0.1 mmHg at 25°C |
| Index of Refraction | 1.375 |
| Storage condition | −20°C |
| Stability | Stable, but may form explosive peroxides in contact with air. Extremely flammable - note low flash point. Incompatible with strong oxidizing agents. |
| Water Solubility | 51 g/L (20 ºC) |
| Freezing Point | -108.6℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H315 |
| Precautionary Statements | P210 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US) |
| Hazard Codes | F:Flammable |
| Risk Phrases | R11;R38 |
| Safety Phrases | S9-S16-S24-S45-S36/37 |
| RIDADR | UN 2398 3/PG 2 |
| WGK Germany | 3 |
| RTECS | KN5250000 |
| Packaging Group | II |
| Hazard Class | 3 |
| HS Code | 2909199090 |
| Precursor 10 | |
|---|---|
| DownStream 9 | |
| HS Code | 2909199090 |
|---|---|
| Summary | 2909199090. other acyclic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
|
Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters.
Cancer Chemother. Pharmacol. 75(2) , 281-91, (2015) Despite overall successful application to multiple myeloma patients, clinical efficacy of the proteasome inhibitor bortezomib is typically challenged by primary and secondary resistance of unknown ori... |
|
|
Mechanistic Scrutiny Identifies a Kinetic Role for Cytochrome b5 Regulation of Human Cytochrome P450c17 (CYP17A1, P450 17A1).
PLoS ONE 10 , e0141252, (2015) Cytochrome P450c17 (P450 17A1, CYP17A1) is a critical enzyme in the synthesis of androgens and is now a target enzyme for the treatment of prostate cancer. Cytochrome P450c17 can exhibit either one or... |
|
|
Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
J. Steroid Biochem. Mol. Biol. 152 , 142-54, (2015) Androsta-1,4,6-triene-3,17-dione (ATD) is an irreversible steroidal aromatase inhibitor and is marketed as a supplement. It has been reported to effectively reduce estrogen biosynthesis and significan... |
| Propane, 2-methoxy-2-methyl- |
| methyl t-butyl ether |
| Methyl tert-butyl ether |
| ARCOPURE(R) MTBE |
| tert-BuOCH3 |
| tert-butylmethyl ether |
| MTBE |
| Methyl tertiary-butyl ether |
| EINECS 216-653-1 |
| MBT-ETHER |
| tert-butyl methyl ether |
| Methyl -butyl ether |
| Driveron |
| methyl-t-butyl ether |
| (CH3)3COCH3 |
| BOC-L-ARG(MTR)-OH |
| tert-butyl-methyl-ether |
| TBME |
| tert-C4H9OCH3 |
| 2-methoxy-2-methyl |
| 2-Methoxy-2-methylpropane |
| HP-MTBE |
| t-butyl methyl ether |
| MFCD00008812 |
| Methyl 1,1-dimethylethyl ether |
| MTBE,Methyl tert-butyl ether |
| Ether, tert-butyl methyl |
| methyl-tert-butyl ether |
| MTB |